Trupanion

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Trupanion reports robust 2022 growth, eyes international expansion opportunities

Trupanion delivered strong financial performance in 2022, with significant revenue and income growth driven by pet acquisitions and retention strategies.
The company's focus on efficient capital deployment, expansion into new channels, and cash reserve position it well for future growth and profitability.
While facing challenges from pricing dynamics and international expansion, Trupanion's strategic initiatives present opportunities for sustained growth and market expansion.
With a positive outlook for 2023 and a solid foundation of customer data, Trupanion is poised to leverage its strengths and navigate challenges for continued success.

Trupanion reports robust Q1 earnings, eyes global expansion opportunities

Trupanion's Q1 2023 earnings call showcased strong financial performance, strategic focus on managing challenges related to inflation, and opportunities for global expansion and market growth. The company's effective pricing strategies and emphasis on long-term vision position it well for revenue growth and margin expansion in 2023.

Trupanion reports robust Q2 performance, eyes growth opportunities ahead

Trupanion's Q2 2023 performance reflects strong revenue growth, margin stabilization, and strategic cost management.
The company aims for disciplined growth, margin expansion, and sustained ARPU amidst challenges in revenue diversification and cost optimization.
Opportunities lie in continued rate increases, marketing efficiency improvements, and enhanced reporting for customer engagement and financial performance.

Trupanion reports robust Q3 earnings, eyes disciplined growth strategies

Trupanion's Q3 performance reflects strong revenue growth, margin expansion, and improved cash flow, underpinned by pricing power and customer loyalty.
While facing challenges in diversifying revenue streams and entering new markets, the company is well-positioned to leverage growth opportunities and maintain financial stability.
With a focus on disciplined growth, operational efficiency, and strategic investments, Trupanion aims to sustain positive momentum and capitalize on the growing pet insurance market.

Trupanion reports robust Q4 growth, focuses on margin expansion

Trupanion's Q4 performance reflects resilience amid industry challenges, with a strong focus on sustainable growth and financial discipline. The company's strategic initiatives to enhance member experience, prioritize margin expansion, and optimize capital deployment position it well for future opportunities.

Trupanion reports robust Q1 performance amidst market challenges and opportunities

Trupanion's Q1 2024 performance reflects strong revenue growth, margin expansion, and operational improvements driven by customer-centric strategies and efficient capital deployment.
While facing challenges such as inflation impacts and remediation efforts, the company's focus on margin expansion, market opportunities, and strategic initiatives positions it for future growth.
Investors can be optimistic about Trupanion's ability to navigate challenges, capitalize on growth opportunities, and drive profitability through effective pricing and operational efficiency.

Trupanion reports robust Q3 performance, eyes growth opportunities in Europe

Trupanion's Q3 performance reflects strong growth in subscription income and strategic initiatives to drive profitability and market expansion.
While challenges persist with inflation and cost management, the company's focus on efficiency and growth presents opportunities for sustained success.
Investors should note the positive operational improvements, the strategic market expansion into Europe, and the commitment to achieving sustainable margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

EverBank Financial

5 of the Best Stocks to Invest $5,000 in Right Now

Fastly

Lovesac Company

This trio of innovative businesses should mop the floor with the Reddit-rally stocks.

Ignore GameStop and AMC: These Growth Stocks Are Poised to Double

SEATTLE, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP) announced today that the Company will participate in the Raymond James 42nd Annual Institutional Investors Conference on Tuesday, March 2, 2021. Darryl Rawlings, Trupanion's founder and Chief Executive Officer, is scheduled to present virtually at 3:50 pm ET and will participate in virtual meetings with investors throughout the day.

Trupanion Announces Participation at the Raymond James 42nd Annual Institutional Investors Conference

It's not that Zomedica is necessarily a bad pick. The chances of long-term success, though, are higher with another stock.

Why This Pet Stock Is a Better Bet Than Zomedica

Trupanion is a competitively advantaged market leader in the pet insurance industry, which is significantly underpenetrated in its primary market of North America. Trupanion has a strong track record of consistently high revenue growth and has been successful at reinvesting these recurring streams of cash flow at high internal rates of return.

Trupanion: High Growth Compounder In A Massively Underpenetrated Market

Webinar includes experts in pet health and training including TV host and best-selling author Victoria Stilwell, Trupanion's Chief Veterinary Officer, Dr. Steve Weinrauch and Dr. Carrie Jurney, president of Not One More Vet and owner of Jurney Veterinary Neurology

Training for Success: Trupanion Reveals Jedi Mind Tricks for New Pet Parents

The pet medical insurance provider turned in a mixed Q4 performance, but its long-term prospects look solid.

Why Trupanion's Q4 Results Weren't the Cat's Meow

Trupanion, Inc. (TRUP) CEO Darryl Rawlings on Q4 2020 Results - Earnings Call Transcript

SEATTLE, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2020.

Trupanion Reports Fourth Quarter and Full Year 2020 Results

SEACOR Hlds

GCM Grosvenor Inc

Ralph Lauren

Royce Investment Partners, the firm founded by Chuck Royce (Trades, Portfolio), disclosed this week that the firm's top four trades included a new position in GCM Grosvenor Inc. (NASDAQ:GCMG), a position boost in Ralph Lauren Corp. (NYSE:RL) and reductions in SEACOR Holdings Inc. (NYSE:CKH) and Trupanion Inc. (NASDAQ:TRUP).

Top 4 4th-Quarter Trades of Chuck Royce's Firm

GameStop

OrganiGram Holdings Inc.

Pinterest

Block

Teladoc

The Reddit-rally stocks can't hold a candle to the potential of these five growth stocks over the next decade.

Forget AMC and GameStop: These 5 Stocks Are Future 10-Baggers

CrowdStrike

Here's how to put hard-fought money to work in the stock market.

Expecting $1,400 Soon? These 3 Stocks Would've Turned It Into $5,000 -- in Just 1 Year

Chewy

Freshpet

IDEXX Laboratories

PetIQ

PetMed Express

Zomedica

Pet stocks have performed very well recently, and many analysts believe that this trend will continue as the industry grows. The post 7 Pet Stocks for Animal Lovers and Investors Alike appeared first on InvestorPlace.

7 Pet Stocks for Animal Lovers and Investors Alike

Aramark

Liberty Media Corp-Liberty Formula One

Hewlett Packard

Western Digital

As the war between retail investors and Wall Street continues, stocks are on pace for their worst weekly declines in nearly three months.

Top Stocks To Short Today Amid Reddit Mania And Disappointing Johnson & Johnson Data

SEATTLE, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leader in medical insurance for cats and dogs, announced today it will report financial results for its 2020 fourth quarter and full year after the market closes on Wednesday, February 10, 2021. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET.

Trupanion, Inc. Announces Fourth Quarter and Full Year 2020 Earnings Release and Conference Call

Here are my three reasons for scooping up more shares of the pet medical insurance stock.

Why I Just Bought More Trupanion Stock

Bright Horizons Family Solutions

First Horizon National

Annaly Capital

TripAdvisor

After the S&P and Nasdaq ﻿hit record highs on inauguration day for the first time since 1997, backed by strong earnings and Biden-related stimulus and vaccine optimism, the indices traded flat. Using our deep learning algorithms, our AI has crunched the data to give you a set of Top Shorts.

Top Stocks To Short Today As Market Flattens After Hitting Records

Proshares Pet Care ETF

It's time to make money from loving your animals instead of just spending it taking care of them.

Pet Owners: Could Your Love of Pets Help You in the Stock Market?

Brookfield Renewable Partners

3 Stocks That'll Make You Richer in 2021

SEATTLE, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP) announced today that the Company will participate in the 23rd Annual Needham Virtual Growth Conference on Wednesday, January 13, 2021. Darryl Rawlings, Trupanion's founder and Chief Executive Officer, is scheduled to present virtually at 10:00 am ET and will participate in virtual meetings with investors throughout the day.

Trupanion Announces Participation at the 23rd Annual Needham Virtual Growth Conference

Etsy

These supercharged companies have the potential to deliver returns of 1,000% or higher before 2030.

4 Growth Stocks That Can Be 10-Baggers This Decade

Amazon

DexCom

Alphabet

Green Thumb Industries Inc.

Businesses in these fast-growing trends can shine in a young bull market.

4 High-Growth Trends You'll Want to Invest in for 2021

Your $600 stimulus payout could be worth $1,800 or more if you buy into these high-growth companies.

3 Top Stocks That Can Triple Your Stimulus Check

Guardant Health Inc

MongoDB

All three have already made investors a lot of money this year.

3 High-Growth Stocks That'll Make You Richer in 2021 and Beyond

Investors should pass on electric-vehicle manufacturer NIO's $61 billion valuation and buy into these superior growth stocks.

Forget NIO: 3 Hypergrowth Stocks to Buy Instead

News for Trupanion Stock (TRUP)